Statistics
Publications
301
Citations
84.4K
Authors
28
Location
Omsk, Russia
301
Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations
Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 708 citations · Full text
Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text
Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6
J.F.R. Robertson, Igor Bondarenko, Ekaterina Trishkina et al. · The Lancet · 2016 · 580 citations · Full text
1–5 of 301
28
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
76 publications · 11K citations
28
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
154 publications · 6.7K citations
15
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
14 publications · 895 citations
7
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
8 publications · 2.8K citations
6
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
18 publications · 424 citations
6
h-index
1–5 of 28